In an on‐target off‐tumor ROR1 toxicity model, the SNIP CARs could be finely tuned by adjusting grazoprevir dosing, thereby sparing healthy cells expressing low levels of ROR1, while effectively eliminating ROR1‐expressing tumor cells. Here, ROR1 is linked to neoplasm.